Literature DB >> 22349167

Microbiota: Dysbiosis driven by inflammasome deficiency exacerbates hepatic steatosis and governs rate of NAFLD progression.

Natalie J Wood.   

Abstract

Entities:  

Year:  2012        PMID： 22349167     DOI： 10.1038/nrgastro.2012.21

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962
  1 in total
  10 in total

Review 1.  Gut-liver axis: role of inflammasomes.

Authors:  Manan Bawa; Vivek A Saraswat
Journal:  J Clin Exp Hepatol       Date:  2013-04-15

Review 2.  The intestinal microbiota: its role in health and disease.

Authors:  Luc Biedermann; Gerhard Rogler
Journal:  Eur J Pediatr       Date:  2015-01-07       Impact factor: 3.183

Review 3.  Antifibrotic therapies in the liver.

Authors:  W Z Mehal; D Schuppan
Journal:  Semin Liver Dis       Date:  2015-05-14       Impact factor: 6.115

Review 4.  From NAFLD to NASH to cirrhosis-new insights into disease mechanisms.

Authors:  Alexander Wree; Lori Broderick; Ali Canbay; Hal M Hoffman; Ariel E Feldstein
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-08-20       Impact factor: 46.802

Review 5.  The CF gastrointestinal microbiome: Structure and clinical impact.

Authors:  Geraint B Rogers; Michael R Narkewicz; Lucas R Hoffman
Journal:  Pediatr Pulmonol       Date:  2016-10

Review 6.  Endoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseases.

Authors:  Beichu Guo; Zihai Li
Journal:  Front Genet       Date:  2014-07-25       Impact factor: 4.599

Review 7.  Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis.

Authors:  Sergio Quesada-Vázquez; Gerard Aragonès; Josep M Del Bas; Xavier Escoté
Journal:  Cells       Date:  2020-01-10       Impact factor: 6.600

8.  A new role for inflammasomes: sensing the disturbances in non-alcoholic fatty liver disease.

Authors:  Poorvi Desai; Prasanna Tamarapu Parthasarathy; Lakshmi Galam; Richard Lockey; Narasaiah Kolliputi
Journal:  Front Physiol       Date:  2013-07-01       Impact factor: 4.566

9.  Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice.

Authors:  Yvonne Ritze; Gyöngyi Bárdos; Anke Claus; Veronika Ehrmann; Ina Bergheim; Andreas Schwiertz; Stephan C Bischoff
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

10.  Chaihu-Shugan-San Decoction Modulates Intestinal Microbe Dysbiosis and Alleviates Chronic Metabolic Inflammation in NAFLD Rats via the NLRP3 Inflammasome Pathway.

Authors:  Yinji Liang; Yupei Zhang; Yuanjun Deng; Shu Liang; Yifang He; Yanning Chen; Chan Liu; Chenli Lin; Li Han; Guifang Tu; Qinhe Yang
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-11       Impact factor: 2.629
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.